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Gut associated lymphoid tissue (GALT) represents the lar-
gest reservoir of HIV-1. The aim of the study is: 1) to
establish the viral and cellular characteristics of the HIV-1
rectal reservoir from chronically infected men under anti-
retroviral therapy (ART) for more than one year and less
than five years, and, 2) to correlate the size of the rectal
reservoir and the cellular composition of rectal mucosa to
the level of CD4+ T cells in blood at the start of ART.
For each patient, whole blood and six rectal biopsies
were collected. Total HIV DNA and cell-associated HIV
RNA were quantified in PBMCs and in rectal samples by
rtPCR assays. The cellular composition of blood and rectal
samples in CD4+ and CD8+ T cells, Th17 lymphocytes,
regulatory T cells (Treg), CD4+/p24+ and CD8+/ PD-1+
T cells was established by flow cytometry.
Up to now, 12 patients were enrolled: 4 with pre-ART
CD4+ T cell count above 350/mm3, 3 between 200 and
350/mm3 and 5 under 200/mm3. The mean HIV DNA
level in rectal cells was lower in patients who initiated ART
with a blood CD4+ T cell count > 350/mm3, compared to
those who started ART with a blood CD4+ T cell count <
200/mm3 (3.49 vs 3.74 log10 copies/106 cells). Moreover,
the rate of rectal CD8+ T cells exhibiting an exhausted
phenotype (CD8+/ PD-1+ T cells) tended to be negatively
correlated to the pre-ART blood CD4+ T cell count (p =
0.06, rho = -0.61) and to the rectal [Th17/Treg] ratio (p =
0.058, rho = -0.66).
These preliminary results suggest that initiating ART
with a high blood CD4+ T cells (> 350/mm3) limits the
size of the HIV rectal reservoir and preserve local immu-
nity, even after long-term therapy. This could participate
to decrease local inflammation and viral replication. The
study is still ongoing to increase the size of the effective
and to complete these results by detecting viral integrated
and 2LTR DNA forms, investigating co-infections agents
and studying the inflammatory environment.
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